Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1299

3′-sialyllactose sodium salt produced via fermentation using production strain Escherichia coli “SLIS109”

Intended Use: As an ingredient in foods, including infant formula, at the maximum levels shown in Table 1 in the response letter.
Basis: Scientific procedures
Notifier: Synaura Biotechnology (Shanghai) Co., Ltd.
Notifier Address: Building 2, Lane 500, Furong Hua Road, Pudong New Area
Shanghai
CHINA
GRAS Notice (releasable information): GRN 1299 (in PDF) (6.9 MB)
Date of closure: May 13, 2026
FDA's Letter: FDA has no questions (in PDF) (299 kB)
-
-